Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
HealthLynked Corp (HLYK)
Price$2.60Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1M | $3.0M | $5.7M | $5.4M | $5.8M | $4.7M | $4.0M | $2.3M | $2.1M | — |
| Operating expenses | $4.2M | $7.7M | $9.9M | $14.5M | $11.8M | $9.2M | $7.2M | $5.2M | $3.9M | $3.1M |
| Operating income | −$2.1M | −$4.7M | −$4.2M | −$8.7M | −$5.3M | −$3.1M | −$3.2M | −$3.0M | −$1.8M | −$1.2M |
| Operating margin | −102.32% | −155.49% | −72.55% | −160.14% | −92.49% | −64.75% | −79.85% | −131.57% | −85.16% | — |
| EBITDA | −$2.0M | −$4.4M | −$3.8M | −$7.8M | −$4.5M | −$2.8M | −$3.1M | −$2.9M | −$1.8M | −$1.2M |
| EBITDA margin | −97.39% | −146.08% | −66.40% | −144.80% | −78.13% | −59.54% | −78.02% | −130.52% | −84.03% | — |
| Net income | −$3.3M | −$6.1M | −$1.0M | −$8.8M | −$10.4M | −$5.8M | −$5.5M | −$5.8M | −$2.6M | −$1.4M |
| Net profit margin | −158.83% | −203.81% | −17.69% | −163.03% | −180.64% | −121.32% | −137.57% | −256.34% | −122.70% | — |
| Basic EPSper basic share | -$1.16 | -$2.18 | $0.00 | -$4.00 | -$5.00 | -$4.00 | -$6.00 | -$7.00 | -$4.00 | -$2.00 |
| Diluted EPSper diluted share | -$1.16 | -$2.18 | $0.00 | -$4.00 | -$5.00 | -$4.00 | -$6.00 | -$7.00 | -$4.00 | -$2.00 |
Owners
Reported shareholders
<0.01%of listed shares
Ancora Advisors LLC74 shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Ancora Advisors LLC | <0.01%74 shares |
Percentages use 2.95M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data